The Cutting Edge

March 2011
PN;Mar2011, Vol. 65 Issue 3, p13
Trade Publication
The article highlights several studies on multiple sclerosis (MS) in the U.S. The Food and Drug Administration has approved Gilenya capsules from Novartis International AG which reduces MS relapses. Oral Cladribine was found to reduce relapse rates in people with MS compared to placebo. Several grants on chronic cerebrospinal venous insufficiency are supported by the National MS Society (NMSS) and the MS Society of Canada.


Related Articles

  • The UK MS Clinical Trials Network: bringing the MS community together to advance research into the condition. Bonnar, Kim // British Journal of Neuroscience Nursing;Apr/May2014, Vol. 10 Issue 2, p60 

    The author discusses the support and funding of the UK MS Clinical Trials Network (UK MS CTN) by research organizations Medical Research Council UK and the MS Society to the establishment of the MS Secondary progressive Multi-Arm Randomisation Trial (MS-SMART) in Great Britain. The licensure for...

  • Leading MS Org Changes Name.  // New Mobility;Jan2010, Vol. 21 Issue 196, p12 

    The article reports on the move of the Heuga Center for Multiple Sclerosis organization to change its name to Can Do MS to reflect its growing role as a unique educator in November 2009 in the U.S.

  • MS clinical research: the next generation.  // Inside MS;Dec2005/Jan2006, Vol. 23 Issue 6, p36 

    The article reports on the inauguration of the Multiple Sclerosis Cooperative Research Group (MS-CORE) by the National MS Society. To stimulate collaboration in the MS research, specifically in the clinical trials of drugs for MS, the Society inaugurated its MS-CORE, with Steven Schwid of the...

  • The three cures for MS. Richert, John // Inside MS;Dec2005/Jan2006, Vol. 23 Issue 6, p39 

    The article focuses on several measures undertaken by the National Multiple Sclerosis Society to treat MS. The Society is committed to finding cure for MS. It has supported therapeutic trials and genetics research. It has awarded $15.6 million to four international collaborative research groups....

  • DMSG-InfoGuide aktualisiert.  // Ergotherapie & Rehabilitation;Apr2012, Vol. 51 Issue 4, p11 

    The publication of the 2012/2013 edition of an informational guide by the Deutsche Multiple Sklerose Gesellschaft (German Multiple Sclerosis Society, DMSG) on the symptoms and treatments of multiple sclerosis is announced.

  • What the Society Has Contributed to Progress Against MS.  // Inside MS;Jun/Jul2007, Vol. 25 Issue 3, p41 

    The article focuses on the contributions of the National MS Society to the progress in the treatment of multiple sclerosis (MS). The Society is investing $45 million in support of more than 380 MS research projects in 2007. The efforts undertaken by the Society to upgrade the care available to...

  • PULSE.  // Current Health Kids;Sep2010, Vol. 34 Issue 1, p4 

    This section offers information related to health, including baseball All-Star third baseman Ryan Zimmerman's establishment of the ziMS Foundation to raise money to combat multiple sclerosis, the Web site, www.fruitsandveggiesmatter.gov, which provides information on different fruits and...

  • Nissan man in charity drive on R.A.C. Rally.  // Motor Sport News: The Voice of British Motorsport;11/9/2011, p15 

    The article reports on the charity drive of former Formula 1000 rally champion, Mick Smith, at the 2011 Roger Albert Clark (R.A.C.) Rally in a 1000cc Nissan Micra for the Multiple Sclerosis (MS) Society.

  • Member revolt at MS Society. Colborne, Femke // Third Sector;7/20/2010, Issue 624, p2 

    The article provides information on the opposition of the members of the Multiple Schlerosis Society in Great Britain to the decision to close its four respite care centres.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics